SCHEMBL396553

SCHEMBL396553

CCc1ccccc1C(=O)Oc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.59
HPGD P15428 2/20 0.59
ALOX15 P16050 2/20 0.59
MAPT P10636 4/20 0.56
KDM4E B2RXH2 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
ALDH1A1 P00352 5/20 0.47
TSHR P16473 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 3/20 0.46
NR4A2 P43354 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CHRM1 P11229 1/20 0.46
TBXA2R P21731 1/20 0.46
SLC6A2 P23975 1/20 0.46
PDE4A P27815 1/20 0.46
ADRA1A P35348 1/20 0.46
KDR P35968 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7921362 0.88 HSD17B10 (0.54) HSD17B10HPGDALOX15MAPTKDM4E
SCHEMBL27533457 0.88 PTK2B (0.59) HSD17B10HPGDALOX15MAPTALDH1A1
SCHEMBL10361052 0.87 HSD17B10 (0.61) HSD17B10HPGDALOX15MAPTKDM4E
SCHEMBL5687689 0.86 HPGD (0.45) HSD17B10HPGDALOX15MAPTKDM4E
SCHEMBL28456642 0.86 MAPT (0.54) HSD17B10HPGDALOX15MAPTKDM4E
SCHEMBL5599878 0.85 HPGD (0.59) HSD17B10HPGDALOX15MAPTKDM4E
SCHEMBL1789266 0.85 HPGD (0.51) HSD17B10HPGDALOX15MAPTKDM4E
SCHEMBL2008036 0.85 MAPT (0.53) HSD17B10HPGDALOX15MAPTKDM4E
SCHEMBL9175351 0.84 ALDH1A1 (0.46) HSD17B10HPGDALOX15MAPTKDM4E
SCHEMBL13121723 0.84 HSD17B10 (0.58) HSD17B10HPGDALOX15MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 711 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230340375-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2023-10-26 US claimed
US-11732222-B2 Consumer product compositions with perfume encapsulates THE PROCTER & GAMBLE COMPANY (US) 2023-08-22 US claimed
US-20200283705-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES THE PROCTER & GAMBLE COMPANY 2020-09-10 US claimed
US-20190209441-A1 GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR WELLA OPERATIONS US, LLC 2019-07-11 US claimed
US-20190192408-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR WELLA OPERATIONS US, LLC 2019-06-27 US claimed
US-20190175476-A1 HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR WELLA OPERATIONS US, LLC 2019-06-13 US claimed
WO-2018053183-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR NOXELL CORPORATION (US) 2018-03-22 WO claimed
WO-2018053065-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR THE PROCTER & GAMBLE COMPANY (US) 2018-03-22 WO claimed
EP-3295925-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR Noxell Corporation (US) 2018-03-21 EP claimed
WO-2018048924-A1 GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR NOXELL CORPORATION (US) 2018-03-15 WO claimed
EP-0805673-A1 PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME THE PROCTER & GAMBLE COMPANY (US) 1997-11-12 EP claimed
EP-0790820-A1 PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME THE PROCTER & GAMBLE COMPANY (US) 1997-08-27 EP claimed
EP-0787177-A1 DETERGENT COMPOSITIONS CONTAINING ENDURING PERFUME THE PROCTER & GAMBLE COMPANY (US) 1997-08-06 EP claimed
US-5540853-A CLEANING COMPOUNDS, PERFUMES, SURFACTANTS AND CARRIERS THE PROCTER & GAMBLE COMPANY (US) 1996-07-30 US claimed
WO-1996012467-A1 PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME THE PROCTER & GAMBLE COMPANY (US) 1996-05-02 WO claimed
WO-1996012786-A1 DETERGENT COMPOSITIONS CONTAINING ENDURING PERFUME THE PROCTER & GAMBLE COMPANY (US) 1996-05-02 WO claimed
WO-1996012468-A1 PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME THE PROCTER & GAMBLE COMPANY (US) 1996-05-02 WO claimed
US-5500138-A QUATERNARY AMMONIUM COMPOUND, LONG LASTING PERFUME, BETTER DEPOSITION ON FABRICS THE PROCTER & GAMBLE COMPANY (US) 1996-03-19 US claimed
US-5500137-A Fabric softening bar compositions containing fabric softener and enduring perfume THE PROCTER & GAMBLE COMPANY (US) 1996-03-19 US claimed
US-4305920-A FOR POLYMERIZATION CATALYST MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1981-12-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190192408-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR MAL2, MSH6, OR51E2 HSD17B10 739/4885HPGD 707/4885ALOX15 630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.